Professor of Surgery, Department of Thoracic and Cardiovascular Surgery, UT MD Anderson Cancer Ctr
Thoracic Surgery
Dr. Ara A. Vaporciyan, MD
|
|
Give Review
Vaporciyan works in the field of Thoracic Surgery. He studied medicine at University of Michigan Medical School. He received 2 awards: "Regional Top Doctor" and "Fellow (FACS)". Vaporciyan is a published MD. He published 86 publications, including: 'Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.' Vaporciyan accepts Medicare payments and is registered with Medicare.gov.
Publications
- Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
- Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer.
- The Use of Intraoperative Dexmedetomidine is Not Associated With a Reduction in Acute Kidney Injury After Lung Cancer Surgery.
- Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung Cancer.
- Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management.
- Radiographic evaluation of the Pleural fluid accumulation rate after pneumonectomy.
- Dexmedetomidine Does Not Reduce Atrial Fibrillation After Lung Cancer Surgery.
- Apples and oranges: Understanding what our trainees need.
- Telomere length and recurrence risk after curative resection in patients with early-stage non-small cell lung Cancer: a prospective cohort study.
- Online learning in thoracic surgical training: promising results of multi-institutional pilot study.
- Preoperative chemotherapy prior to Pulmonary metastasectomy in surgically resected primary colorectal carcinoma.
- Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lun...
- The Looking to the Future Medical Student Program: Recruiting Tomorrow's Leaders.
- The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma.
- Clinical Course of Breast Cancer Patients with Isolated Sternal and Full-Thickness Chest Wall Recurrences Treated With and Without Radical Surgery.
- Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up.
- Visceral pleural invasion is not predictive of survival in patients with lung Cancer and smaller tumor size.
- Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroEsophageal cancer: analysis ...
- Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung Cancer, with implications for patient selection for adjuvant radiati...
- Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery.
- Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer.
- Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with Esophageal cancer.
- Patients with high body mass index tend to have lower stage of Esophageal carcinoma at diagnosis.
- Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma.
- Contemporary Surgical Management of Cardiac Paragangliomas.
- Perceptions and expectations of cardiothoracic residents and attending surgeons.
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy.
- Follow-up of Patients with Resected Thoracic Malignancies.
- Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non-Small Cell Lung Cancer Patients.
- Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?
- Improved survival after resection of liver and Lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited Lung metastatic dis...
- Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals.
- Progression after chemotherapy is a novel predictor of poor outcomes after Pulmonary metastasectomy in sarcoma patients.
- The prognostic factors of chest wall metastasis resection.
- Automated symptom alerts reduce postoperative symptom severity after Cancer surgery: a randomized controlled clinical trial.
- The influence of high body mass index on the prognosis of patients with Esophageal cancer after surgery as primary therapy.
- Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroEsophageal junction.
- Factors dominating choice of surgical specialty.
- Association of age and survival in patients with gastroEsophageal cancer undergoing surgery with or without preoperative therapy.
- Impact of tumor length on long-term survival of pT1 Esophageal adenocarcinoma.
- Application of the revised lung Cancer staging system (IASLC Staging Project) to a Cancer center population.
- Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung Cancer.
- Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era.
- Superior sulcus Tumors with vertebral body involvement: a multimodality approach.
- Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents.
- Management of primary pulmonary Artery sarcomas.
- Esophageal tumor length is independently associated with long-term survival.
- Defining N2 Disease in non-small cell lung cancer.
- 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
- Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung Cancer.
- Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit express...
- Cardiac autotransplantation for malignant or complex primary left-Heart tumors.
- Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung Cancer.
- Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for Malignant pleural mesothelioma.
- Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or...
- The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with Esophageal adenocarcinoma.
- Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in Esophageal cancer patients treated with concurrent chemoradio...
- Histologic subtypes as determinants of outcome in Esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
- Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in Esophageal adenocarcinoma.
- Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
- The evolution of treatment outcomes for resected stage IIIA non-small cell lung Cancer over 16 years at a single institution.
- Long-segment, supercharged, pedicled jejunal flap for total Esophageal reconstruction.
- Tumor cavitation in stage I non-small cell lung Cancer: epidermal growth factor receptor expression and prediction of poor outcome.
- Intrathoracic leaks following esophagectomy are no longer associated with increased mortality.
- Integrated computed tomography-positron emission tomography in patients with potentially resectable Malignant pleural mesothelioma: Staging implications.
- Proposed revision of the Esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
- Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus.
- Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III Esophageal cancer patients.
- 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with es...
- Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical Esophageal resection.
- Risk factors associated with Atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.
- The potential role of aprotinin in the perioperative management of malignant Tumors.
- Hormone replacement therapy and lung Cancer risk: a case-control analysis.
- Postoperative pulmonary complications after preoperative chemoradiation for Esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
- Chondrosarcoma arising in the trachea: a case report and review of the literature.
- Promising early local control of Malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest.
- Evaluating the role of serine protease inhibition in the management of tumor micrometastases.
- Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced Esophageal cancer.
- Intensity-modulated radiation therapy: a novel approach to the management of Malignant pleural mesothelioma.
- Unusual cause of dyspnea after pneumonectomy.
- Induction of p53-regulated genes and tumor regression in lung Cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
- Treatment outcomes of resected Esophageal cancer.
- Incidence of major Pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.
- Salvage esophagectomy for recurrent Tumors after definitive chemotherapy and radiotherapy.
- Commentary: integrated surgical residency initiative: implications for cardiothoracic surgery.
Schools
Univ Of Mi Med Sch
Mem Hermann Hlthcare Sys
Texas Heart Institute
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
- Decortication and Pleurectomy
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Embolism and Thrombosis
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiac Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACS)
Education
-
University of Michigan Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1114013091 | |
| NPPES Provider LastName | VAPORCIYAN | |
| NPPES Provider FirstName | ARA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Thoracic Surgery | |
| Total Claim Count | 77.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 31.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114013091 |
| Last Name Of The Provider | VAPORCIYAN |
| First Name Of The Provider | ARA |
| View All |
Similar Doctors
|
Dr. Philip A. Rascoe, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph S. Coselli, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Stephen G. Swisher, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Min P. Kim, MD |
|
|
Dr. Gerald M. Lawrie, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Richard M. Alexander, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey S. Heinle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garrett L. Walsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth L. Mattox, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott A. LeMaire, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Hazim J. Safi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anthony L. Estrera, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Emilio B. Hisse, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gonzalo M. Vargas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip R. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shabir Bhimji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jim S. Garza, MD
This Doctor is OpenDoctor Recommended.
|